2004 Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | < 1999

  • Jiang X, Rossanese OW, Brown NF, Kujat-Choy S, Galan JE, Finlay BB, Brumell JH. The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice.Mol Microbiol. 2004 Dec;54(5):1186-98.[abstract]
  • Coombes BK, Valdez Y, Finlay BB. Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr Biol. 2004 Oct 5;14(19):R856-67. Review. [abstract]
  • Coombes BK, Brown NF, Valdez Y, Brumell JH, Finlay BB.Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. J Biol Chem. 2004 Nov 26;279(48):49804-15. Epub 2004 Sep 20. [abstract]
  • Zaharik ML, Cullen VL, Fung AM, Libby SJ, Kujat Choy SL, Coburn B, Kehres DG, Maguire ME, Fang FC, Finlay BB. The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect Immun. 2004 Sep;72(9):5522-5. [abstract]
  • Conlin VS, Curtis SB, Zhao Y, Moore ED, Smith VC, Meloche RM, Finlay BB, Buchan AM. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect Immun. 2004 Sep;72(9):5181-92. [abstract]
  • Kujat Choy SL, Boyle EC, Gal-Mor O, Goode DL, Valdez Y, Vallance BA, Finlay BB. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium. Infect Immun. 2004 Sep;72(9):5115-25. [abstract]
  • Coombes BK, Hardwidge PR, Finlay BB.Interpreting the host-pathogen dialogue through microarrays. Adv Appl Microbiol. 2004;54:291-331. [link]
  • Finlay BB, See RH, Brunham RC.Rapid response research to emerging infectious diseases: lessons from SARS. Nat Rev Microbiol. 2004 Jul;2(7):602-7. Review. No abstract available. [link]
  • Pollard AJ, Currie A, Rosenberger CM, Heale JP, Finlay BB, Speert DP. Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates.Cell Microbiol. 2004 Jul;6(7):639-50. [abstract]
  • Bertelsen LS, Paesold G, Marcus SL, Finlay BB, Eckmann L, Barrett KE. Am J Physiol Cell Physiol. 2004 Oct;287(4):C939-48. Epub 2004 Jun 02. [abstract]
  • Maaser C, Housley MP, Iimura M, Smith JR, Vallance BA, Finlay BB, Schreiber JR, Varki NM, Kagnoff MF, Eckmann L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.Infect Immun. 2004 Jun;72(6):3315-24. [abstract]
  • Finlay BB, Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol. 2004 Jun;2(6):497-504. Review. No abstract available. [abstract]
  • Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, Fang FC. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol. 2004 May 15;172(10):6202-8. [abstract]
  • Harrison RE, Brumell JH, Khandani A, Bucci C, Scott CC, Jiang X, Finlay BB, Grinstein S. Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol Biol Cell. 2004 Jul;15(7):3146-54. Epub 2004 Apr 30. [abstract]
  • Thomas NA, Finlay BB. Pathogens: bacterial needles ruled to length and specificity. Curr Biol. 2004 Mar 9;14(5):R192-4. Review. [abstract]
  • Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vazquez A, Barba J, Ibarra JA, O’Donnell P, Metalnikov P, Ashman K, Lee S, Goode D, Pawson T, Finlay BB. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3597-602. Epub 2004 Feb 26. [abstract]
  • Hardwidge PR, Rodriguez-Escudero I, Goode D, Donohoe S, Eng J, Goodlett DR, Aebersold R, Finlay BB. Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli. J Biol Chem. 2004 May 7;279(19):20127-36. Epub 2004 Feb 26. [abstract]
  • Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2422-7. [abstract]
  • Gruenheid S, Sekirov I, Thomas NA, Deng W, O’Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol. 2004 Mar;51(5):1233-49. [abstract]
  • Zaharik ML, Finlay BB. Mn2+ and bacterial pathogenesis. Front Biosci. 2004 May 01;9:1035-42. Print 2004 May 1. Review. [abstract]
  • Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A. 2004 Feb 11 [abstract]
  • potter aa, klashinsky s, li y, frey e, townsend h, rogan d, erickson g, hinkley s, klopfenstein t, moxley ra, smith dr, finlay bb. (jan 2) 2004. Decreased shedding of escherichia coli o157:h7 by cattle following vaccination with type iii secreted proteins. vaccine 22(3-4): 362-9.[abstract]